FEB 04, 2016 10:03 AM PST

Proton Therapy Zaps More Cancer, Less Healthy Cells

Childhood brain cancers may fare better with proton beam therapy than conventional radiotherapies, say researchers from the Massachusetts General Hospital (MGH). Their latest study was recently published in The Lancet Oncology.
Proton therapy for cancer has less side effects

Medulloblastoma is of the most common and deadly form of pediatric brain cancer. The malignant tumor cells rapidly grow out of control at the base of the brain, near the cerebellum. There, they aggressively metastasize through the cerebral spinal fluid to other locations on the brain and spine cord. Once the medulloblastoma spreads, the five-year survival rate drops to about 60%.
Though catching and treating the cancer early is generally considered a good thing, medulloblastoma treatments have so far been a double-edged sword for the pediatric patients. Once diagnosed, the children typically undergo surgeries for removal, followed by intense photon radiotherapy and chemotherapy. These treatments kill the cancer cells, but they also kill the healthy cells in the children’s fragile but rapidly growing brains. Patients often develop cognitive deficits along with other organ problems as a due to radiation exposure. As a result, earlier treatments are often associated with severe long-term side effects.
To reduce the collateral damages to healthy brain cells, researchers turned to proton therapy. Also known as proton beam therapy, the treatment uses the ionizing power of protons to damage the DNA of cancer cells, and thus kill them. X-rays do the same thing, but proton beams can do it in a more targeted fashion, reducing the amount of damage to healthy cells.
Led by Dr. Torunn Yock of MGH, the research team evaluated the outcome of proton therapy in children with medulloblastomas. All 59 patients had surgeries to remove the tumors, and then were subsequently treated with proton beam therapy. Patients also received chemotherapy in conjunction with the proton treatment. Researchers charted the patients’ response to the treatments over the course of 8 years.
Though they found that though proton therapy didn’t improve patient survival rates, the side effects were reduced. For example, at five years post treatment, 16% of patients displayed hearing loss, compared to the 25% reported in studies using conventional radiotherapy.
Other cognitive functions, such as verbal comprehension and processing speed, though affected, were not as deficient than that reported with photon therapy. Most significantly, the children who received proton therapy did not have any side effects in the heart, lungs, or intestines. These organs are commonly affected in traditional photon therapies.
The findings show that proton beam treatment is as effective as traditional methods, but is less toxic to the patients.

"I truly believe that - particularly for the youngest children - the ability to offer them proton therapy can make a big difference in their lives." – Dr. Yock, senior study author.

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 21, 2019
Genetics & Genomics
OCT 21, 2019
Utilizing CRISPR Technology for Digital Detection of Genetic Material
Graphene has long been known for its semiconductor capabilities and now it's being put to work in biosensors. Kiana Aran, Ph.D., Co-Founder of Nanosens, Assistant Professor of Biomedical...
OCT 21, 2019
Health & Medicine
OCT 21, 2019
Mental Health Disorders Among Elite Athletes
Mental health disorders are common among elite athletes (those who competed at the professional, Olympic, or collegiate/university levels) with d...
OCT 21, 2019
OCT 21, 2019
3D-Printed Pipette Technology Advances Laboratory Testing
The need to design a simple and inexpensive laboratory method for medical tests has encouraged new technology developed by the University of Connecticut re...
OCT 21, 2019
Health & Medicine
OCT 21, 2019
Rumors Disrupt Efforts To Control Ebola Outbreak
In the Democratic Republic of Congo (DRC), there is some doubt that Ebola is a real disease. Locals sometimes claim the illness was “brought in ...
OCT 21, 2019
Cell & Molecular Biology
OCT 21, 2019
Discovery of Bone Bits in Blood may Help Explain Vascular Calcification
As we age, calcium can build up in various tissues in the body, and cause them to harden in a process called calcification....
OCT 21, 2019
Clinical & Molecular DX
OCT 21, 2019
AcroMetrix BCR-ABL External Molecular Panel: An Accurate Testing Method for Chronic Myeloid Leukemia
To support the validation and verification of new assays in oncology testing, Thermo Fisher Scientific with AcroMetrix control products provides innov...
Loading Comments...